(TRIAL TERMINATED - problems with recruitment) Effects of guiding informal caregivers of terminal cancer patients who stay at home, by district nurses who are specialised in palliative care/oncology

ISRCTN ISRCTN37522734
DOI https://doi.org/10.1186/ISRCTN37522734
Secondary identifying numbers 25073; NTR157
Submission date
20/12/2005
Registration date
20/12/2005
Last edited
10/08/2009
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms Marta van Dijk
Scientific

Integraal Kankercentrum Limburg
P.O.Box 2208
Maastricht
6201 HA
Netherlands

Phone +31 (0)43 325 4059
Email m.vandijk@ikl.nl

Study information

Study designMulticentre, randomised, active controlled, parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific title
Study acronymGids-project (Guidance of informal carers by district nurses)
Study objectivesInformal caregivers in the experimental group are expected to be more satisfied with the care provided to them and the patient they take care of, to experience a less heavy burden, and to have a better health compared to the informal caregivers who are assigned to the control group and will receive standard care.
Ethics approval(s)Received from the local medical ethics committee
Health condition(s) or problem(s) studiedTerminal cancer
InterventionFour one-hour home visits by district nurses who are specialised in palliative care/oncology over a period of six weeks, in order to support informal caregivers in handling problems they are faced with when taking care of a terminally ill cancer patient.

Next to the visits of the district nurses, informal caregivers in the experimental group receive written information about self-care for informal caregivers and contact with other informal caregivers. They also receive information about national and local organizations involved in the care for informal caregivers.
Intervention typeOther
Primary outcome measure1. Satisfaction of the informal caregivers with the care provided to them and the patient they take care of. Measured at baseline and eight weeks later, with the Maastricht measuring-Instrument Satisfaction Terminal Care (in Dutch: Maastrichts meetInstrument Tevredenheid Terminale Zorg - MITTZ).
2. Burden perceived by the informal caregivers, measured at baseline and eight weeks later, with the Caregiver Reaction Assessment-Dutch (CRA-D)
3. Health of the informal caregivers, measured at baseline and eight weeks later, with the MOS 36-item Short Form Health Survey (SF-36)
Secondary outcome measuresThe use of health care facilities by both the informal caregivers and the patients, measured over a period of eight weeks, by means of a care diary.
Overall study start date15/04/2005
Completion date28/02/2006
Reason abandoned (if study stopped)Problems with recruitment

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants90
Key inclusion criteriaInformal caregivers can enter the study if they take care of a patient who has been diagnosed with cancer and has a life expectancy of less than four months. Next to these criteria, the patient has to spend his last months largely at home and has to be at least 18 years old. Informal caregivers can also take part in the study if they are not involved in the care for the patient at the moment, but are expected to be in the near future.
Key exclusion criteriaInformal caregivers who take care of a cancer patient with a life expectancy of less than two months, because this interferes with the post-measurement eight weeks after inclusion
Date of first enrolment15/04/2005
Date of final enrolment28/02/2006

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Integraal Kankercentrum Limburg
Maastricht
6201 HA
Netherlands

Sponsor information

Comprehensive Cancer Centre Limburg (The Netherlands)
Charity

P.O. Box 2208
Maastricht
6201 HA
Netherlands

Funders

Funder type

Government

Province of Limburg (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan